Join Now

Resources for Members Dealing with COVID-19

Utah Life Sciences by the Numbers

Kem C. Gardner Report Findings Nov. 2023

Utah is #3 in the nation for life sciences growth.

Life sciences is a $21.6 billion industry in Utah.

Source: Pace, L. and Brandley, A. (2023), Economic Impacts of Utah’s Life Sciences and Health Care Innovation Industry: Utah’s Life Sciences and Health Care Innovation Industry Creates Substantial Economic Impacts Across the State, Kem C. Gardner Policy Institute, University of Utah.

BioUtah News

October 8, 2026
Co-Diagnostics Announces First Full Vector Smart® Laboratory Installation for Native American Tribe

Ute Indian Tribe Mosquito Abatement Department to bring PCR-based mosquito surveillance testing in house

October 8, 2026
October 8, 2026
Co-Diagnostics Highlights Vector Smart® Momentum Following New Federal Initiative on Vector-Borne Disease

New Executive Order prioritizes improved detection and calls for federal R&D programs for rapid diagnostics for mosquito- and tick-borne diseases

October 8, 2026
BlueWind Medical Announces Humana Coverage of Revi® for Urgency Urinary Incontinence, Expanding Access to Millions of Patients

BlueWind Medical Announces Humana Coverage of Revi® for Urgency Urinary Incontinence, Expanding Access to Millions of Patients

October 8, 2026
Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

Myriad Genetics and SOPHiA GENETICS Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

October 8, 2026
BD and U.S. Government Launch Landmark Partnership to Expand U.S. Manufacturing and Strengthen America’s Healthcare Resilience

Agreement supports significant investments in U.S. manufacturing, strengthens healthcare resilience and increases domestic production of essential medical consumables used in approximately 90% of U.S. hospital visits  

October 8, 2026
DiscGenics Announces Leadership Transition as IDCT Advances Through Pivotal Phase III Development

DiscGenics Announces Leadership Transition as IDCT Advances Through Pivotal Phase III Development

October 8, 2026
Renew Biotechnologies Enters Collaboration to Evaluate NeuroLens® in Multiple Sclerosis and Related Neuroimmunologic Diseases

Cell-of-origin insights could deepen understanding of CNS injury and disease progression in multiple sclerosis and related diseases

2025 Utah Life Sciences Award Recipients

Lifetime Achievement
Dr. Wes Sundquist

Innovation Impact
Nusano

Entrepreneur of the Year
Shawn Fojtik

Executive of the Year
Fred Lampropoulos

Friend of Industry
Dr. Taylor Randall

BioUtah is Powered by

Legacy Sponsors

Platinum Sponsors

Gold Sponsors

Silver Sponsors

Bronze Sponsors